Source link : https://newshealth.biz/health-news/adding-tucatinib-in-first-line-maintenance-boosts-pfs-in-her2-positive-breast-cancer/
(MedPage Today) — At the San Antonio Breast Cancer Symposium, investigators presented results from HER2CLIMB-05, a registrational trial evaluating the addition of tucatinib (Tukysa) to trastuzumab (Herceptin) and pertuzumab (Perjeta) maintenance… Source link : https://www.medpagetoday.com/meetingcoverage/sabcsvideopearls/119134 Author : Publish date : 2025-12-22 17:56:00 Copyright for syndicated content belongs to the linked Source.
The post Adding Tucatinib in First-Line Maintenance Boosts PFS in HER2-Positive Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-22 17:56:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8